U.S. patent number 3,721,233 [Application Number 05/085,530] was granted by the patent office on 1973-03-20 for t-shaped tracheal stent.
Invention is credited to Eugene B. Hood, William W. Montgomery.
United States Patent |
3,721,233 |
Montgomery , et al. |
March 20, 1973 |
T-SHAPED TRACHEAL STENT
Abstract
A T-shaped stent for use following surgical reconstruction of
the cervical trachea and surgical correction of tracheal and
subglottic stenosis. The stent comprises a tubular intraluminal
portion and a tubular tracheotomy portion connected thereto between
its ends and provided with a removable plug. The tubular portions
are of a resiliently yieldable stock enabling the ends of the
intraluminal portion to be folded together or against the
tracheotomy portion for insertion and removal through a tracheotomy
orifice. The intraluminal portion provides internal support for the
repaired part of the trachea and the cross sectional area of the
tracheotomy portion increases at its junction with the intraluminal
portion to an axial extent such that external tapering surfaces are
provided for entry into the posterior end of the orifice to provide
molding support for and overcorrecting the inferior margin of
adjacent portions of the anterior tracheal wall.
Inventors: |
Montgomery; William W.
(Wellesley, MA), Hood; Eugene B. (Duxbury, MA) |
Family
ID: |
22192230 |
Appl.
No.: |
05/085,530 |
Filed: |
October 30, 1970 |
Current U.S.
Class: |
128/207.14 |
Current CPC
Class: |
A61M
16/0465 (20130101) |
Current International
Class: |
A61M
16/04 (20060101); A61m 016/00 () |
Field of
Search: |
;128/1R,33R,351 |
References Cited
[Referenced By]
U.S. Patent Documents
Foreign Patent Documents
Primary Examiner: Pace; Channing L.
Claims
We claim:
1. A T-shaped stent for insertion through a tracheotomy orifice
into a trachea following surgical reconstruction of the cervical
portion thereof, and surgical correction of tracheal and subglottic
stenosis, said stent comprising an intraluminal tubular portion
open at both ends and whose outside diameter is such as to provide
a snugly fitting internal support for the reconstructed or
corrected part of the trachea, and an integral tracheotomy tubular
portion of a diameter less than that of the intraluminal portion
and disposed at an angle thereto intermediate the ends thereof and
in communication with the interior of said intraluminal portion,
and said tracheotomy portion being of a length to project outwardly
through a tracheotomy orifice after the disposition of the
intraluminal portion within a trachea through said orifice, the
junction of the two portions being ovate with its long axis
lengthwise of the intraluminal portion and providing external
flared shoulders lengthwise of both portions and of substantial
axial such as to provide, when the stent is in place, molding
surfaces for entry into the interior end of the tracheotomy orifice
in molding support of the margin of adjacent margins of the
tracheal wall and operable to overcorrect said margins thereby to
avoid the protrusion of any resulting scar tissue into the trachea,
said stent being of resiliently yieldable stock enabling one end of
the intraluminal portion to be folded against the tracheotomy
portion or both ends thereof to be folded together for insertion
and removal through said orifice, and means releasably closing the
exposed end of the tracheotomy portion.
2. The T-shaped stent of claim 1 in which the external molding
surfaces of the tracheotomy portion are arcuate with their radius
varying with the diameter of the intraluminal portion.
Description
The present invention relates to T-shaped tracheal stents and a
scar tissue controlling method for use following surgical
reconstruction of the cervical portion of the trachea and surgical
correction of tracheal and subglottic stenosis.
The present invention relates to T-shaped tracheal stents and a
scar tissue controlling method for use following surgical
reconstruction of the cervical portion of the trachea and surgical
correction of tracheal and subglottic stenosis.
We developed a T-shaped stent for insertion into the trachea in the
zone where is was reconstructed or corrected, the stent consisting
of an intraluminal tube and a tracheotomy tube joined thereto
between its ends. Both tubes were of a soft flexible material,
silicone rubber in practice, that had sufficient resiliency to
enable the stent to be readily deformed by folding one of its
intraluminal portions against the tracheotomy portion or with both
intraluminal portions folded together for entry or removal through
the tracheotomy and also to conform, when inserted, to normal
contours of the trachea and yet provide good support therefor.
These stents have been used with success in a substantial number of
operations. While their use clearly promotes healing, it has been
noted that after the tracheal orifice has healed, scar tissue will
often be found that projects into the tracheal passage to a
troublesome extent.
The principal objective of the invention is to provide a T-shaped
stent possessed of the virtues of the one whose construction was
just summarized and that will prevent the resulting scar tissue
from being a troublesome problem. In accordance with the invention,
this objective is attained by providing that the tracheotomy tube
has, at its junction with the intraluminal tube, a cross sectional
area that so increases towards the intraluminal tube as to provide
external surfaces that taper through a predetermined axial zone
thus to provide molding surfaces for entry into the posterior end
of the tracheotomy to overcorrect the inferior margins of adjacent
portions of the anterior tracheal wall and thereby prevent
objectionable scar tissue from ultimately projecting into the
tracheal passage.
A particular objective of the invention is to have such molding
surfaces disposed towards the opposite ends of the intraluminal
portion.
Yet another objective of the invention is to provide that the
junction between the two tubular portions provides internal
surfaces that are flared towards the ends of the intraluminal
portions thus to facilitate the introduction of a catheter into an
intraluminal portion through the tracheotomy portions if its use
becomes necessary.
Another objective of the invention is to provide a method by which
scar tissue at the posterior end of a tracheal orifice can be
prevented from being an interference within the trachea, an
objective attained by overconnecting the inferior layer of portions
of the anterior tracheal wall adjacent the orifice with a molding
tracheotomy support.
In the accompanying drawings, there is shown an embodiment of the
invention illustrative of these and other of its objectives, novel
features, and advantages.
In the drawings:
FIG. 1 is a section taken vertically through the trachea
illustrating the introduction of one end of the intraluminal
portion of the stent into the surgically established tracheal
orifice;
FIG. 2 is a like view illustrating the entered end of the stent
being inserted downwardly into the trachea;
FIG. 3 is a view similar to FIG. 2 illustrating the introduction of
the other end of the intraluminal portion into the trachea to
extend upwardly therein;
FIG. 4 is a like view illustrating the final step in positioning
the installed stent;
FIG. 5 is another like view showing the installed stent with a plug
inserted in the exposed end of its tracheotomy portion;
FIG. 6 is a side elevation of a stent in accordance with the
invention; and
FIG. 7 is a view of the stent as seen from the free end of the
tracheotomy portion.
A T-shaped tracheal stent in accordance with the invention is
generally indicated at 10 and, as may best be seen in FIGS. 6 and
7, it comprises an intraluminal portion 11 and a tubular
tracheotomy portion 12 of a somewhat smaller diameter and joined to
the portion 11 between the ends thereof with the lower portion
slightly longer than the upper portion. The portion 11 has both of
its ends inwardly curved as at 13 while the outer or free end of
the tracheotomy portion 12 is inwardly curved as at 14 and is
closed by a stopper or plug 15. The portions 11 and 12 are of a
soft, resiliently yieldable material such as silicone rubber that
is relatively inert. In practice, the wall thickness of the tubular
portions 11 and 12 is in the neighborhood of 1.5 mil and their
outside diameters vary as the stents are made available to meet
requirements ranging from male adults to infants as the
intraluminal portions must fit the trachea 16 snugly to provide
support therefor. By way of example, the outside diameter of the
intraluminal portion for pediatric uses is 8 mm, that for
adolescents 10 mm, while the adult sizes are 12 mm, 14 mm, and 16
mm. Either end of the portion 11 may be trimmed if necessary. The
stent 10, as thus far described is substantially that previously
referred to as having been successfully used for some time.
In accordance with the invention, the cross sectional area of the
tracheotomy tube 12 is increased to have a cross sectional area
greater than that of the tracheotomy orifice through an appreciable
axial zone where it joins the intraluminal tube 11 to provide
tapering surfaces for entry into the posterior end of the
tracheotomy orifice 17 and provide molding support therefor. As
shown in the drawings, the increased cross sectional area is such
that the molding surfaces are in the form of shoulders 18, each
disposed toward an end of the intraluminal portion 11, the molding
shoulders being for use in overcorrecting the inferior margin of
the anterior tracheal wall adjacent the tracheotomy orifice 17. In
practice, the shoulders are arcuate with the radius varying with
the diameter of the intraluminal portion in the neighborhood of
five thirty-seconds of an inch with the 12 mm intraluminal tube.
This construction provides another advantageous feature since it
results in the junction between the tubes being in the form of a
mouth 19, see FIG. 6, flared towards the ends of the intraluminal
portion 11 to enable catheter insertion to be more easily effected
than is the case with a substantially right angular junction.
Such a stent is installed through the tracheotomy orifice 17
following surgical reconstruction of the cervical portion of the
trachea 16 or correction of tracheal and subglottic stenosis.
Reference is made to FIGS. 1 - 4 to show the manner in which the
stent 10 is installed.
A stent 10 is selected for use having the diameter of its
intraluminal portion 11 such as to provide a supporting fit for the
patient's trachea when inserted therein. As shown in FIG. 1, the
end of the stent portion 11 that is to extend upwardly in the
trachea is gripped by forceps 20 by which the other end may be
entered into and pushed through the tracheotomy orifice 17 and
downwardly into the trachea 16. As will be apparent from FIG. 2,
the inwardly curved end 13 facilitates such entry.
In FIG. 3, it will be noted that as the forceps-held end of the
portion 11 is forced through the tracheotomy orifice, the stent
collapses at the junction of the portions 11 and 12. The stent
portion 11 is then released and the outer end of the tubular
portion 12 is then gripped by the forceps with an outward pull
moving the intraluminal portion into a position supporting the
cervical portion of the trachea and the shoulders 18 into molding
contact with the posterior end of the tracheotomy to overcorrect
the inferior margin 16A of the reconstructed or reconstituted
anterior tracheal wall, see FIG. 5, thus to prevent any resulting
scar tissue from projecting into the trachea when the tracheotomy
has healed. By way of example, anterior tracheal stenosis is a
collapse or buckling in of the anterior tracheal wall requiring
surgery to enable the tracheal rings to be repositioned or the
anterior wall supported by the sternohyoid muscles. In either case,
scar tissue is present that must be removed and a stent in
accordance with the invention prevents recurrence of scar tissue
formation and thus prevents recurrent stenosis.
* * * * *